Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

被引：0
|
作者：
O. Katopodis
J. Souglakos
E. Stathopoulos
A. Christopoulou
E. Kontopodis
A. Kotsakis
K. Kalbakis
N. Kentepozidis
A. Polyzos
D. Hatzidaki
V. Georgoulias
机构：
[1] Hellenic Oncology Research Group (HORG),
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Gemcitabine; Oxaliplatin; Erlotinib; Phase II trial; Pancreas;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 340
页数：7
相关论文
共 50 条
  • [41] Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer
    Stathopoulos, GP
    Rigatos, SK
    Dimopoulos, MA
    Giannakakis, T
    Foutzilas, G
    Kouroussis, C
    Janninis, D
    Aravantinos, G
    Androulakis, N
    Agelaki, S
    Stathopoulos, JG
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2003, 14 (03) : 388 - 394
  • [42] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    J. Feliu
    P. Borrega
    A. León
    L. López-Gómez
    M. López
    J. Castro
    C. Belda-Iniesta
    J. Barriuso
    V. Martínez
    M. González-Barón
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 215 - 221
  • [43] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [44] First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
    Sgouros, Joseph
    Aravantinos, Gerasimos
    Koliou, Georgia-Angeliki
    Pentheroudakis, George
    Zagouri, Flora
    Psyrri, Amanda
    Lampropoulou, Dimitra Ioanna
    Demiri, Stamatina
    Pectasides, Dimitrios
    Razis, Evangelia
    Fountzilas, George
    Samantas, Epaminontas
    ANTICANCER RESEARCH, 2020, 40 (02) : 929 - 938
  • [45] Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
    Pectasides, D
    Aravantinos, G
    Kalofonos, H
    Kiamouris, C
    Bafaloukos, D
    Xiros, N
    Nicolaides, C
    Visvikis, A
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2001, 12 (10) : 1417 - 1422
  • [46] Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the hellenic cooperative oncology group (HeCOG)
    Timotheadou, E
    Papakostas, P
    Tsavdaridis, D
    Basdanis, G
    Kalofonos, H
    Aravantinos, G
    Bafaloukos, D
    Fountzilas, G
    TUMORI JOURNAL, 2005, 91 (04): : 309 - 313
  • [47] Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
    E Van Cutsem
    C-P Li
    E Nowara
    G Aprile
    M Moore
    I Federowicz
    J-L Van Laethem
    C Hsu
    C K Tham
    S M Stemmer
    R Lipp
    A Zeaiter
    A Fittipaldo
    Z Csutor
    B Klughammer
    X Meng
    T Ciuleanu
    British Journal of Cancer, 2014, 111 : 2067 - 2075
  • [48] Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
    Van Cutsem, E.
    Li, C-P
    Nowara, E.
    Aprile, G.
    Moore, M.
    Federowicz, I.
    Van Laethem, J-L
    Hsu, C.
    Tham, C. K.
    Stemmer, S. M.
    Lipp, R.
    Zeaiter, A.
    Fittipaldo, A.
    Csutor, Z.
    Klughammer, B.
    Meng, X.
    Ciuleanu, T.
    BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2067 - 2075
  • [49] A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296)
    Berlin, JD
    Adak, S
    Vaughn, DJ
    Flinker, D
    Blaszkowsky, L
    Harris, JE
    Benson, AB
    ONCOLOGY, 2000, 58 (03) : 215 - 218
  • [50] Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
    Fountzilas, G
    Stathopoulos, G
    Nicolaides, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Nikolaou, A
    Bacoyiannis, C
    Samantas, E
    Papadimitriou, C
    Kosmidis, P
    Daniilidis, J
    Pavlidis, N
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 475 - 478
12345